Correlation Between Heart Test and NanoVibronix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Heart Test and NanoVibronix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Heart Test and NanoVibronix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Heart Test Laboratories and NanoVibronix, you can compare the effects of market volatilities on Heart Test and NanoVibronix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Heart Test with a short position of NanoVibronix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Heart Test and NanoVibronix.

Diversification Opportunities for Heart Test and NanoVibronix

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Heart and NanoVibronix is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Heart Test Laboratories and NanoVibronix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NanoVibronix and Heart Test is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Heart Test Laboratories are associated (or correlated) with NanoVibronix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NanoVibronix has no effect on the direction of Heart Test i.e., Heart Test and NanoVibronix go up and down completely randomly.

Pair Corralation between Heart Test and NanoVibronix

Given the investment horizon of 90 days Heart Test Laboratories is expected to under-perform the NanoVibronix. But the stock apears to be less risky and, when comparing its historical volatility, Heart Test Laboratories is 3.75 times less risky than NanoVibronix. The stock trades about -0.08 of its potential returns per unit of risk. The NanoVibronix is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  659.00  in NanoVibronix on December 30, 2024 and sell it today you would lose (282.00) from holding NanoVibronix or give up 42.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Heart Test Laboratories  vs.  NanoVibronix

 Performance 
       Timeline  
Heart Test Laboratories 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Heart Test Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
NanoVibronix 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NanoVibronix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Heart Test and NanoVibronix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Heart Test and NanoVibronix

The main advantage of trading using opposite Heart Test and NanoVibronix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Heart Test position performs unexpectedly, NanoVibronix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NanoVibronix will offset losses from the drop in NanoVibronix's long position.
The idea behind Heart Test Laboratories and NanoVibronix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Correlations
Find global opportunities by holding instruments from different markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance